Pharmaceuticals Market Research Reports & Industry Analysis

Publications found: 36,694
Sort by:

Bullous pemphigoid - Pipeline Insight, 2021

US$ 1,500.00

This report can be delivered to the clients within 3-4 Business Days DelveInsight’s, “Bullous pemphigoid - Pipeline Insight, 2021,” report provides comprehensive insights about 8+ companies and 8+ p...

October 2021 60 pages

Carcinoid Syndrome - Pipeline Insight, 2021

US$ 1,500.00

This report can be delivered to the clients within 24 hours DelveInsight’s, “Carcinoid Syndrome - Pipeline Insight, 2021,” report provides comprehensive insights about 3+ companies and 3+ pipeline d...

October 2021 60 pages

Fibrodysplasia ossificans progressiva - Pipeline Insight, 2021

US$ 1,500.00

This report can be delivered to the clients within 72 hours DelveInsight’s, “Fibrodysplasia ossificans progressiva - Pipeline Insight, 2021,” report provides comprehensive insights about 10+ compani...

October 2021 60 pages

Gaucher’s Disease - Pipeline Insight, 2021

US$ 1,500.00

This report can be delivered to the clients within 48 hours DelveInsight’s, “Gaucher’s Disease - Pipeline Insight, 2021,” report provides comprehensive insights about 14+ companies and 16+ pipeline...

October 2021 60 pages

Lyme Disease - Pipeline Insight, 2021

US$ 1,500.00

This report can be delivered to the clients within 72 hours DelveInsight’s, “Lyme Disease - Pipeline Insight, 2021,” report provides comprehensive insights about 7+ companies and 7+ pipeline drugs i...

October 2021 60 pages

Muscle Spasticity - Pipeline Insight, 2021

US$ 1,500.00

This report can be delivered to the clients within 48 hours DelveInsight’s, “Muscle Spasticity – Pipeline Insight, 2021,” report provides comprehensive insights about 8+ companies and 8+ pipeline dr...

October 2021 60 pages

Neurofibromatosis - Pipeline Insight, 2021

US$ 1,500.00

This report can be delivered to the clients within 48 hours DelveInsight’s, “Neurofibromatosis - Pipeline Insight, 2021,” report provides comprehensive insights about 10+ companies and 10+ pipeline...

October 2021 60 pages

Presbyopia - Pipeline Insight, 2021

US$ 1,500.00

This report can be delivered to the clients within 48 hours DelveInsight’s, “Presbyopia - Pipeline Insight, 2021,” report provides comprehensive insights about 10+ companies and 10+ pipeline drugs i...

October 2021 60 pages

Primary Ciliary Dyskinesia - Pipeline Insight, 2021

US$ 1,500.00

This report can be delivered to the clients within 24 hours DelveInsight’s, “Primary Ciliary Dyskinesia – Pipeline Insight, 2021,” report provides comprehensive insights about 4+ companies and 4+ pi...

October 2021 60 pages

Chronic Rhinosinusitis - Pipeline Insight, 2021

US$ 1,500.00

This report can be delivered to the clients within 48 hours DelveInsight’s, “Chronic Rhinosinusitis - Pipeline Insight, 2021,” report provides comprehensive insights about 6+ companies and 6+ pipeli...

October 2021 60 pages

Inflammation and Pain Post Cataract Surgery - Pipeline Insight, 2021

US$ 1,500.00

This report can be delivered to the clients within 24 hours DelveInsight’s, “Inflammation and Pain Post Cataract Surgery – Pipeline Insight, 2021,” report provides comprehensive insights about 3+ co...

October 2021 60 pages

Keloids - Pipeline Insight, 2021

US$ 1,500.00

This report can be delivered to the clients within 24 hours DelveInsight’s, “Keloids - Pipeline Insight, 2021,” report provides comprehensive insights about 4+ companies and 4+ pipeline drugs in Kel...

October 2021 60 pages

Ocular Inflammation and Pain - Pipeline Insight, 2021

US$ 1,500.00

This report can be delivered to the clients within 24 hours DelveInsight’s, “Ocular Inflammation and Pain – Pipeline Insight, 2021,” report provides comprehensive insights about 5+ companies and 5+...

October 2021 60 pages

Hemochromatosis - Pipeline Insight, 2021

US$ 1,500.00

This report can be delivered to the clients within 24 hours DelveInsight’s, “Hemochromatosis – Pipeline Insight, 2021,” report provides comprehensive insights about 5+ companies and 5+ pipeline drug...

October 2021 60 pages

Immune Thrombocytopenic Purpura - Pipeline Insight, 2021

US$ 1,500.00

This report can be delivered to the clients within 48 hours DelveInsight’s, “Immune Thrombocytopenic Purpura - Pipeline Insight, 2021,” report provides comprehensive insights about 18+ companies and...

October 2021 60 pages

Osteonecrosis - Pipeline Insight, 2021

US$ 1,500.00

This report can be delivered to the clients within 24 hours DelveInsight’s, “Osteonecrosis – Pipeline Insight, 2021,” report provides comprehensive insights about 4+ companies and 4+ pipeline drugs...

October 2021 60 pages

Peritoneal Cancer - Pipeline Insight, 2021

US$ 2,500.00

This report can be delivered to the clients within 5-6 business days DelveInsight’s, “Peritoneal cancer – Pipeline Insight, 2021,” report provides comprehensive insights about 50+ companies and 50+...

October 2021 60 pages

Recurrent anaplastic astrocytomas - Pipeline Insight, 2021

US$ 1,500.00

This report can be delivered to the clients within 48 hours DelveInsight’s, “Recurrent anaplastic astrocytomas – Pipeline Insight, 2021,” report provides comprehensive insights about 6+ companies an...

October 2021 60 pages

Antisense Oligonucleotide Therapeutics - Pipeline Insight, 2021

US$ 1,500.00

This report can be delivered to the clients within 48-72 hours DelveInsight’s, “Antisense Oligonucleotide Therapeutics – Pipeline Insight, 2021,” report provides comprehensive insights about 15+ com...

October 2021 60 pages

TIL therapy - Pipeline Insight, 2021

US$ 1,500.00

This report can be delivered to the clients within 48-72 hours DelveInsight’s, “TIL therapy – Pipeline Insight, 2021,” report provides comprehensive insights about 15+ companies and 20+ pipeline dru...

October 2021 60 pages

Abbvie Nine Months 2021 Review and Outlook-Strategic SWOT Analysis, Performance, Capabilities, Goals and Strategies in the Global Pharmaceutical Industry

US$ 750.00

This report is part of the LeadingMarketResearch.com Competitive Analysis Series, which includes assessments of more than 1,000 companies worldwide. The report provides significant competitor informat...

October 2021 -

Akorn Nine Months 2021 Review and Outlook-Strategic SWOT Analysis, Performance, Capabilities, Goals and Strategies in the Global Pharmaceutical Industry

US$ 750.00

This report is part of the LeadingMarketResearch.com Competitive Analysis Series, which includes assessments of more than 1,000 companies worldwide. The report provides significant competitor informat...

October 2021 -

Alexion Pharmaceuticals Nine Months 2021 Review and Outlook-Strategic SWOT Analysis, Performance, Capabilities, Goals and Strategies in the Global Pharmaceutical Industry

US$ 750.00

This report is part of the LeadingMarketResearch.com Competitive Analysis Series, which includes assessments of more than 1,000 companies worldwide. The report provides significant competitor informat...

October 2021 -

Allergan Nine Months 2021 Review and Outlook-Strategic SWOT Analysis, Performance, Capabilities, Goals and Strategies in the Global Pharmaceutical Industry

US$ 750.00

This report is part of the LeadingMarketResearch.com Competitive Analysis Series, which includes assessments of more than 1,000 companies worldwide. The report provides significant competitor informat...

October 2021 -

Alnylam Pharmaceuticals Nine Months 2021 Review and Outlook-Strategic SWOT Analysis, Performance, Capabilities, Goals and Strategies in the Global Pharmaceutical Industry

US$ 750.00

This report is part of the LeadingMarketResearch.com Competitive Analysis Series, which includes assessments of more than 1,000 companies worldwide. The report provides significant competitor informat...

October 2021 -

Amgen Nine Months 2021 Review and Outlook-Strategic SWOT Analysis, Performance, Capabilities, Goals and Strategies in the Global Pharmaceutical Industry

US$ 750.00

This report is part of the LeadingMarketResearch.com Competitive Analysis Series, which includes assessments of more than 1,000 companies worldwide. The report provides significant competitor informat...

October 2021 -

AstraZeneca Nine Months 2021 Review and Outlook-Strategic SWOT Analysis, Performance, Capabilities, Goals and Strategies in the Global Pharmaceutical Industry

US$ 750.00

This report is part of the LeadingMarketResearch.com Competitive Analysis Series, which includes assessments of more than 1,000 companies worldwide. The report provides significant competitor informat...

October 2021 -

Aurora Cannabis Nine Months 2021 Review and Outlook-Strategic SWOT Analysis, Performance, Capabilities, Goals and Strategies in the Global Pharmaceutical Industry

US$ 750.00

This report is part of the LeadingMarketResearch.com Competitive Analysis Series, which includes assessments of more than 1,000 companies worldwide. The report provides significant competitor informat...

October 2021 -

Bayer Nine Months 2021 Review and Outlook-Strategic SWOT Analysis, Performance, Capabilities, Goals and Strategies in the Global Pharmaceutical Industry

US$ 750.00

This report is part of the LeadingMarketResearch.com Competitive Analysis Series, which includes assessments of more than 1,000 companies worldwide. The report provides significant competitor informat...

October 2021 -

Biogen Nine Months 2021 Review and Outlook-Strategic SWOT Analysis, Performance, Capabilities, Goals and Strategies in the Global Pharmaceutical Industry

US$ 750.00

This report is part of the LeadingMarketResearch.com Competitive Analysis Series, which includes assessments of more than 1,000 companies worldwide. The report provides significant competitor informat...

October 2021 -

Bristol-Myers Squibb Nine Months 2021 Review and Outlook-Strategic SWOT Analysis, Performance, Capabilities, Goals and Strategies in the Global Pharmaceutical Industry

US$ 750.00

This report is part of the LeadingMarketResearch.com Competitive Analysis Series, which includes assessments of more than 1,000 companies worldwide. The report provides significant competitor informat...

October 2021 -

Canopy Growth Nine Months 2021 Review and Outlook-Strategic SWOT Analysis, Performance, Capabilities, Goals and Strategies in the Global Pharmaceutical Industry

US$ 750.00

This report is part of the LeadingMarketResearch.com Competitive Analysis Series, which includes assessments of more than 1,000 companies worldwide. The report provides significant competitor informat...

October 2021 -

Celgene Nine Months 2021 Review and Outlook-Strategic SWOT Analysis, Performance, Capabilities, Goals and Strategies in the Global Pharmaceutical Industry

US$ 750.00

This report is part of the LeadingMarketResearch.com Competitive Analysis Series, which includes assessments of more than 1,000 companies worldwide. The report provides significant competitor informat...

October 2021 -

Ceva Nine Months 2021 Review and Outlook-Strategic SWOT Analysis, Performance, Capabilities, Goals and Strategies in the Global Animal Health Industry

US$ 750.00

This report is part of the LeadingMarketResearch.com Competitive Analysis Series, which includes assessments of more than 1,000 companies worldwide. The report provides significant competitor informat...

October 2021 -

Cronos Group Nine Months 2021 Review and Outlook-Strategic SWOT Analysis, Performance, Capabilities, Goals and Strategies in the Global Pharmaceutical Industry

US$ 750.00

This report is part of the LeadingMarketResearch.com Competitive Analysis Series, which includes assessments of more than 1,000 companies worldwide. The report provides significant competitor informat...

October 2021 -

Curaleaf Nine Months 2021 Review and Outlook-Strategic SWOT Analysis, Performance, Capabilities, Goals and Strategies in the Global Pharmaceutical Industry

US$ 750.00

This report is part of the LeadingMarketResearch.com Competitive Analysis Series, which includes assessments of more than 1,000 companies worldwide. The report provides significant competitor informat...

October 2021 -

Dr Reddy's Laboratories Nine Months 2021 Review and Outlook-Strategic SWOT Analysis, Performance, Capabilities, Goals and Strategies in the Global Pharmaceutical Industry

US$ 750.00

This report is part of the LeadingMarketResearch.com Competitive Analysis Series, which includes assessments of more than 1,000 companies worldwide. The report provides significant competitor informat...

October 2021 -

Elanco Nine Months 2021 Review and Outlook-Strategic SWOT Analysis, Performance, Capabilities, Goals and Strategies in the Global Animal Health Industry

US$ 750.00

This report is part of the LeadingMarketResearch.com Competitive Analysis Series, which includes assessments of more than 1,000 companies worldwide. The report provides significant competitor informat...

October 2021 -

Eli Lilly Nine Months 2021 Review and Outlook-Strategic SWOT Analysis, Performance, Capabilities, Goals and Strategies in the Global Pharmaceutical Industry

US$ 750.00

This report is part of the LeadingMarketResearch.com Competitive Analysis Series, which includes assessments of more than 1,000 companies worldwide. The report provides significant competitor informat...

October 2021 -

Endo Pharmaceuticals Nine Months 2021 Review and Outlook-Strategic SWOT Analysis, Performance, Capabilities, Goals and Strategies in the Global Pharmaceutical Industry

US$ 750.00

This report is part of the LeadingMarketResearch.com Competitive Analysis Series, which includes assessments of more than 1,000 companies worldwide. The report provides significant competitor informat...

October 2021 -

Exelixis Nine Months 2021 Review and Outlook-Strategic SWOT Analysis, Performance, Capabilities, Goals and Strategies in the Global Pharmaceutical Industry

US$ 750.00

This report is part of the LeadingMarketResearch.com Competitive Analysis Series, which includes assessments of more than 1,000 companies worldwide. The report provides significant competitor informat...

October 2021 -

Gilead Sciences Nine Months 2021 Review and Outlook-Strategic SWOT Analysis, Performance, Capabilities, Goals and Strategies in the Global Pharmaceutical Industry

US$ 750.00

This report is part of the LeadingMarketResearch.com Competitive Analysis Series, which includes assessments of more than 1,000 companies worldwide. The report provides significant competitor informat...

October 2021 -

GlaxoSmithKline Nine Months 2021 Review and Outlook-Strategic SWOT Analysis, Performance, Capabilities, Goals and Strategies in the Global Pharmaceutical Industry

US$ 750.00

This report is part of the LeadingMarketResearch.com Competitive Analysis Series, which includes assessments of more than 1,000 companies worldwide. The report provides significant competitor informat...

October 2021 -

Green Thumb Nine Months 2021 Review and Outlook-Strategic SWOT Analysis, Performance, Capabilities, Goals and Strategies in the Global Pharmaceutical Industry

US$ 750.00

This report is part of the LeadingMarketResearch.com Competitive Analysis Series, which includes assessments of more than 1,000 companies worldwide. The report provides significant competitor informat...

October 2021 -

Incyte Nine Months 2021 Review and Outlook-Strategic SWOT Analysis, Performance, Capabilities, Goals and Strategies in the Global Pharmaceutical Industry

US$ 750.00

This report is part of the LeadingMarketResearch.com Competitive Analysis Series, which includes assessments of more than 1,000 companies worldwide. The report provides significant competitor informat...

October 2021 -

Intercept Pharmaceuticals Nine Months 2021 Review and Outlook-Strategic SWOT Analysis, Performance, Capabilities, Goals and Strategies in the Global Pharmaceutical Industry

US$ 750.00

This report is part of the LeadingMarketResearch.com Competitive Analysis Series, which includes assessments of more than 1,000 companies worldwide. The report provides significant competitor informat...

October 2021 -

Ionis Pharmaceuticals Nine Months 2021 Review and Outlook-Strategic SWOT Analysis, Performance, Capabilities, Goals and Strategies in the Global Pharmaceutical Industry

US$ 750.00

This report is part of the LeadingMarketResearch.com Competitive Analysis Series, which includes assessments of more than 1,000 companies worldwide. The report provides significant competitor informat...

October 2021 -

Jazz Pharmaceuticals Nine Months 2021 Review and Outlook-Strategic SWOT Analysis, Performance, Capabilities, Goals and Strategies in the Global Pharmaceutical Industry

US$ 750.00

This report is part of the LeadingMarketResearch.com Competitive Analysis Series, which includes assessments of more than 1,000 companies worldwide. The report provides significant competitor informat...

October 2021 -

Johnson & Johnson Nine Months 2021 Review and Outlook-Strategic SWOT Analysis, Performance, Capabilities, Goals and Strategies in the Global Pharmaceutical Industry

US$ 750.00

This report is part of the LeadingMarketResearch.com Competitive Analysis Series, which includes assessments of more than 1,000 companies worldwide. The report provides significant competitor informat...

October 2021 -

Kite Pharma Nine Months 2021 Review and Outlook-Strategic SWOT Analysis, Performance, Capabilities, Goals and Strategies in the Global Pharmaceutical Industry

US$ 750.00

This report is part of the LeadingMarketResearch.com Competitive Analysis Series, which includes assessments of more than 1,000 companies worldwide. The report provides significant competitor informat...

October 2021 -

Filters

Search

Categories

153
299
490
372
93
184
386
14,910
12,134
222
1,273
225
433
345
3,983
72
1,120

Publishers

2,237
1,678
72
37
1
4,083
2,049
451
220
650
292
33
4
2,631
796
123
12
81
339
120
1,132
5
6
6
23
18
40
259
30
34
6,128
13
12
142
363
8
25
84
660
8
14
8
49
197
7
2,296
266
579
2,792
7
24
44
31
54
92
7
2,538
40
34
11
22
16
38
2
4
97
4
26
50
1
214
11
120
36
21
227
32
50
27
32
42
878
54
326
51
88
92
60
37
2
14
22
2

Regions

102
85
28
27
26
26
17
14
10
9
7
7
7
7
6
5
3
3
2
2
1
1,629
258
224
198
178
117
113
104
78
73
61
53
42
42
39
36
35
33
30
30
29
29
20
20
20
19
18
18
17
15
15
15
14
13
13
13
13
13
12
12
12
12
12
11
11
11
11
11
10
10
10
9
7
6
6
5
201
260
22
21
883
256
141
68
57
34
29
6
6
6
6
5
5
4
3
3
5
5
5
4
3
2
1
1
1
1
2
2
462
29,919

Price

—

Date

—

Pages

—

Offers

44
5
1